Guardian Capital LP Regeneron Pharmaceuticals, Inc. Transaction History

Guardian Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $325,665 - $450,909	-1,087 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $133,948 - $158,245	-360 Reduced 24.88%	1,087 $446,000
Q3 2018 Nov 13, 2018	BUY	$351.14 - $408.51 $54,777 - $63,727	156 Added 12.08%	1,447 $585,000
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $367,418 - $445,382	1,291 New	1,291 $445,000

1,480

85.7M

908K

1.3M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $90.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Guardian Capital LP, based on Form 13F filings with the SEC.

Stay updated on Guardian Capital LP with notifications on news.